Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainPINIT

PIAS3 PIAS2

9.50e-054752IPR023321
DomainPINIT

PIAS3 PIAS2

9.50e-054752PS51466
DomainPINIT

PIAS3 PIAS2

9.50e-054752PF14324
Domainzf-MIZ

PIAS3 PIAS2

3.30e-047752PF02891
DomainZF_SP_RING

PIAS3 PIAS2

3.30e-047752PS51044
DomainZnf_MIZ

PIAS3 PIAS2

4.39e-048752IPR004181
DomainRCC1

HERC2 HERC1

2.88e-0320752PF00415
DomainRCC1_1

HERC2 HERC1

3.18e-0321752PS00625
DomainRCC1_2

HERC2 HERC1

3.18e-0321752PS00626
DomainRCC1_3

HERC2 HERC1

3.18e-0321752PS50012
Domain-

PIAS3 PIAS2

3.18e-03217521.10.720.30
DomainEPHD

PHF7 MLLT10

3.49e-0322752PS51805
DomainReg_chr_condens

HERC2 HERC1

3.49e-0322752IPR000408
Domain-

HERC2 HERC1

3.49e-03227522.130.10.30
DomainSAP

PIAS3 PIAS2

3.49e-0322752PF02037
DomainSAP

PIAS3 PIAS2

3.81e-0323752SM00513
DomainRCC1/BLIP-II

HERC2 HERC1

3.81e-0323752IPR009091
DomainSAP

PIAS3 PIAS2

4.50e-0325752PS50800
DomainSAP_dom

PIAS3 PIAS2

4.50e-0325752IPR003034
DomainWD40_repeat

STXBP5L HERC2 HERC1 BRWD3 NSMAF

4.75e-03272755IPR001680
DomainWD_REPEATS_1

STXBP5L HERC2 HERC1 BRWD3 NSMAF

5.21e-03278755PS00678
DomainHECT

HERC2 HERC1

5.23e-0327752PF00632
DomainHECTc

HERC2 HERC1

5.23e-0327752SM00119
DomainHECT_dom

HERC2 HERC1

5.23e-0327752IPR000569
DomainHECT

HERC2 HERC1

5.23e-0327752PS50237
DomainWD_REPEATS_2

STXBP5L HERC2 HERC1 BRWD3 NSMAF

5.29e-03279755PS50082
DomainWD_REPEATS_REGION

STXBP5L HERC2 HERC1 BRWD3 NSMAF

5.29e-03279755PS50294
DomainWD40_repeat_dom

STXBP5L UBR4 HERC1 BRWD3 NSMAF

6.85e-03297755IPR017986
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

HOXB4 TNRC18 ZNF48 KHNYN UBR4 HERC2 MLLT10 HERC1 MBD5 DYSF MYRF REXO1 C6orf132

8.75e-071105771335748872
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

SLAIN2 JCAD FAM171A2 ATXN1 PLEKHG3 FMN2 PLCH1 ARHGEF16 CSPP1 C6orf132 ITPKB

3.03e-06861771136931259
Pubmed

Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

SLAIN2 JCAD MBD5 KANK2 ATP10D

3.45e-0610377510819331
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

TNRC18 ATXN1 PTBP2 STXBP5L PLEKHG3 TBK1 FRMPD2 MBD5 ARHGEF16 ARMC2 BRWD3 NSMAF ITPKB PDZD2

4.38e-061489771428611215
Pubmed

Group IVA phospholipase A₂ optimizes ovulation and fertilization in rodents through induction of and metabolic coupling with prostaglandin endoperoxide synthase 2.

PLA2G4A PTGS2

4.84e-06277222673578
Pubmed

Cyclooxygenase-2 Mediated Oxidation of 2-Arachidonoyl-Lysophospholipids Identifies Unknown Lipid Signaling Pathways.

PLA2G4A PTGS2

4.84e-06277227642067
Pubmed

Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels.

PLA2G4A PTGS2

4.84e-06277220034614
Pubmed

Spatial and temporal alterations of phospholipids determined by mass spectrometry during mouse embryo implantation.

PLA2G4A PTGS2

4.84e-06277219429885
Pubmed

BMPRIA is required for osteogenic differentiation and RANKL expression in adult bone marrow mesenchymal stromal cells.

BMPR1A MAP3K7

4.84e-06277229855498
Pubmed

The impact of PLA2G4A and PTGS2 gene polymorphisms, and red blood cell PUFAs deficit on niacin skin flush response in schizophrenia patients.

PLA2G4A PTGS2

4.84e-06277223219238
Pubmed

BanI polymorphism of cytosolic phospholipase A2 gene and somatic symptoms in medication-free acute depressed patients.

PLA2G4A PTGS2

4.84e-06277228108057
Pubmed

Plasma Levels of Cyclooxygenase-2 (COX-2) and Visfatin During Different Stages and Different Subtypes of Migraine Headaches.

NAMPT PTGS2

4.84e-06277228044053
Pubmed

Cytosolic phospholipase A2 is a key regulator of blood-brain barrier function in epilepsy.

PLA2G4A PTGS2

4.84e-06277231661303
Pubmed

Arachidonic acid regulation of the cytosolic phospholipase A 2α/cyclooxygenase-2 pathway in mouse endometrial stromal cells.

PLA2G4A PTGS2

4.84e-06277222369775
Pubmed

Rnf144b alleviates the inflammatory responses and cardiac dysfunction in sepsis.

RNF144B TBK1

4.84e-06277237088470
Pubmed

Cytosolic phospholipase A2 alpha amplifies early cyclooxygenase-2 expression, oxidative stress and MAP kinase phosphorylation after cerebral ischemia in mice.

PLA2G4A PTGS2

4.84e-06277220673332
Pubmed

The expression of brain cyclooxygenase-2 is down-regulated in the cytosolic phospholipase A2 knockout mouse.

PLA2G4A PTGS2

4.84e-06277214713302
Pubmed

A study of a genetic association between the PTGS2/PLA2G4A locus and schizophrenia.

PLA2G4A PTGS2

4.84e-06277215041036
Pubmed

RKIP and TBK1 form a positive feedback loop to promote type I interferon production in innate immunity.

PEBP1 TBK1

1.45e-05377227753621
Pubmed

No association between the PPARG gene and schizophrenia in a British population.

PLA2G4A PTGS2

1.45e-05377219560328
Pubmed

Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis.

PLA2G4A PTGS2

1.45e-05377218471798
Pubmed

Expression of STAT5, COX-2 and PIAS3 in correlation with NSCLC histhopathological features.

PIAS3 PTGS2

1.45e-05377225137041
Pubmed

BMPR1a signaling determines numbers of oligodendrocytes and calbindin-expressing interneurons in the cortex.

BMPR1A OLIG1

1.45e-05377217626200
Pubmed

Cross-talk between peroxisome proliferator-activated receptor delta and cytosolic phospholipase A(2)alpha/cyclooxygenase-2/prostaglandin E(2) signaling pathways in human hepatocellular carcinoma cells.

PLA2G4A PTGS2

1.45e-05377217178883
Pubmed

PGE2 release is independent of upregulation of Group V phospholipase A2 during long-term stimulation of P388D1 cells with LPS.

PLA2G4A PTGS2

1.45e-05377216150819
Pubmed

Exposure to growth hormone is associated with hepatic up-regulation of cPLA2α and COX.

PLA2G4A PTGS2

1.45e-05377232259636
Pubmed

Phospholipase A(2) and cyclooxygenase gene expression in human preimplantation embryos.

PLA2G4A PTGS2

1.45e-05377212050227
Pubmed

The noncanonical BMP signaling pathway plays an important role in club cell regeneration.

BMPR1A MAP3K7

1.45e-05377231758827
Pubmed

Association study of interferon-γ, cytosolic phospholipase A2, and cyclooxygenase-2 gene polymorphisms in Alzheimer disease.

PLA2G4A PTGS2

1.45e-05377220808133
Pubmed

PIAS genes as disease markers in bipolar disorder.

PIAS3 PIAS2

1.45e-05377230861611
Pubmed

Nicotinamide phosphoribosyltransferase and prostaglandin H2 synthase 2 are up-regulated in human pancreatic adenocarcinoma cells after stimulation with interleukin-1.

NAMPT PTGS2

1.45e-05377219513556
Pubmed

PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.

PIAS3 PIAS2

1.45e-05377212077349
Pubmed

S100B binding to RAGE in microglia stimulates COX-2 expression.

MOK PTGS2

1.45e-05377217023559
Pubmed

Multifaceted Regulation of Akt by Diverse C-Terminal Post-translational Modifications.

MOK NKD1 ARHGEF16 ITPKB

1.72e-056977434941261
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

JCAD LARP6 PIAS3 UBR4 FMN2 HERC2 CMYA5 ZNF439 PIAS2 KANK2 DDX27 BRWD3

2.46e-051285771235914814
Pubmed

Cytosolic phospholipase A2 Group IValpha but not secreted phospholipase A2 Group IIA, V, or X induces interleukin-8 and cyclooxygenase-2 gene and protein expression through peroxisome proliferator-activated receptors gamma 1 and 2 in human lung cells.

PLA2G4A PTGS2

2.89e-05477215331599
Pubmed

DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor.

PIAS3 PIAS2

2.89e-05477211477070
Pubmed

Molecular characterization of murine pancreatic phospholipase A(2).

PLA2G4A PTGS2

2.89e-05477211313018
Pubmed

Impacts of cytosolic phospholipase A2, 15-prostaglandin dehydrogenase, and cyclooxygenase-2 expressions on tumor progression in colorectal cancer.

PLA2G4A PTGS2

2.89e-05477220635443
Pubmed

RNF144B inhibits LPS-induced inflammatory responses via binding TBK1.

RNF144B TBK1

2.89e-05477231509299
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

JCAD TNRC18 PIAS3 UBR4 MLLT10 BSN C6orf132

4.80e-0543077735044719
Pubmed

PIAS proteins are involved in the SUMO-1 modification, intracellular translocation and transcriptional repressive activity of RET finger protein.

PIAS3 PIAS2

4.82e-05577215907835
Pubmed

A study of the combined effect of the CLDN5 locus and the genes for the phospholipid metabolism pathway in schizophrenia.

PLA2G4A PTGS2

4.82e-05577216181776
Pubmed

Inducible LGALS3BP/90K activates antiviral innate immune responses by targeting TRAF6 and TRAF3 complex.

TBK1 MAP3K7

4.82e-05577231404116
Pubmed

The Prostaglandin E2-EP3 Receptor Axis Regulates Anaplasma phagocytophilum-Mediated NLRC4 Inflammasome Activation.

PLA2G4A PTGS2

4.82e-05577227482714
Pubmed

Resistin up-regulates COX-2 expression via TAK1-IKK-NF-kappaB signaling pathway.

MAP3K7 PTGS2

4.82e-05577219774455
Pubmed

SUMO-triggered ubiquitination of NR4A1 controls macrophage cell death.

PIAS3 PIAS2

4.82e-05577228622293
Pubmed

Cytosolic phospholipase A2 regulates TNF-induced production of joint destructive effectors in synoviocytes.

PLA2G4A PTGS2

4.82e-05577224349530
Pubmed

SUMO Modification Reverses Inhibitory Effects of Smad Nuclear Interacting Protein-1 in TGF-β Responses.

PIAS3 PIAS2

4.82e-05577227703003
Pubmed

Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity.

UBR4 HERC2 HERC1 PIAS2

6.07e-059577429643511
Pubmed

A functional deficiency of TERA/VCP/p97 contributes to impaired DNA repair in multiple polyglutamine diseases.

L3MBTL1 ATXN1

7.22e-05677223652004
Pubmed

Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner.

PIAS3 PIAS2

7.22e-05677216029420
Pubmed

AATYK is a Novel Regulator of Oligodendrocyte Differentiation and Myelination.

OLIG1 MYRF

7.22e-05677229556912
Pubmed

SUMOylation of RORalpha potentiates transcriptional activation function.

PIAS3 PIAS2

7.22e-05677219041634
Pubmed

Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.

PEBP1 MAP3K7

7.22e-05677211585904
Pubmed

A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis.

PIAS3 PIAS2

7.22e-05677223704280
Pubmed

Inhibition of Stat1-mediated gene activation by PIAS1.

PIAS3 PIAS2

1.01e-0477729724754
Pubmed

Differential effects of BMP signaling on parvalbumin and somatostatin interneuron differentiation.

BMPR1A OLIG1

1.01e-04777219592576
Pubmed

Phospho-regulated SUMO interaction modules connect the SUMO system to CK2 signaling.

PIAS3 PIAS2

1.01e-04777219217413
Pubmed

The ancestral gene for transcribed, low-copy repeats in the Prader-Willi/Angelman region encodes a large protein implicated in protein trafficking, which is deficient in mice with neuromuscular and spermiogenic abnormalities.

HERC2 HERC1

1.01e-0477729949213
Pubmed

Insight into prostaglandin, leukotriene, and other eicosanoid functions using mice with targeted gene disruptions.

PLA2G4A PTGS2

1.01e-04777210593166
Pubmed

Interactive Repression of MYRF Self-Cleavage and Activity in Oligodendrocyte Differentiation by TMEM98 Protein.

OLIG1 MYRF

1.01e-04777230249802
Pubmed

A human MAP kinase interactome.

PIAS3 ATXN1 HERC2 MBD5 MAP3K7 PIAS2 DDX27

1.03e-0448677720936779
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

FANCD2 JCAD FAM171A2 ZNF174 FMN2 HERC2 HERC1 MAP3K7 CSPP1 DDX27

1.05e-041049771027880917
Pubmed

Cooperation of TLR2 with MyD88, PI3K, and Rac1 in lipoteichoic acid-induced cPLA2/COX-2-dependent airway inflammatory responses.

PLA2G4A PTGS2

1.34e-04877220167866
Pubmed

SUMO modification of TBK1 at the adaptor-binding C-terminal coiled-coil domain contributes to its antiviral activity.

TBK1 PIAS2

1.34e-04877225409927
Pubmed

ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation.

PIAS3 PIAS2

1.34e-04877211117529
Pubmed

Relation of genetic polymorphisms in the cytochrome P450 gene with clopidogrel resistance after drug-eluting stent implantation in Koreans.

CYP1A2 PTGS2

1.34e-04877219576320
Pubmed

Interaction of protein inhibitor of activated STAT (PIAS) proteins with the TATA-binding protein, TBP.

PIAS3 PIAS2

1.34e-04877216522640
Pubmed

Altered expression of inflammation-associated genes in oviductal cells following follicular fluid exposure: implications for ovarian carcinogenesis.

NAMPT PTGS2

1.72e-04977224186266
Pubmed

A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation.

PIAS3 PIAS2

1.72e-04977217533377
Pubmed

VISA is an adapter protein required for virus-triggered IFN-beta signaling.

TBK1 MAP3K7

1.72e-04977216153868
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

FANCD2 SLAIN2 BMPR1A ATXN1 TBK1 FMN2 SREK1 KANK2 BRWD3 GGCX

1.74e-041116771031753913
Pubmed

S100B is selectively expressed by gray matter protoplasmic astrocytes and myelinating oligodendrocytes in the developing CNS.

OLIG1 MYRF

2.15e-041077234615523
Pubmed

Compound mutations in Bmpr1a and Tak1 synergize facial deformities via increased cell death.

BMPR1A MAP3K7

2.63e-041177229411501
Pubmed

The tyrosine kinase Syk differentially regulates Toll-like receptor signaling downstream of the adaptor molecules TRAF6 and TRAF3.

TBK1 MAP3K7

2.63e-041177223962979
Pubmed

Sumoylation of FOXP2 Regulates Motor Function and Vocal Communication Through Purkinje Cell Development.

PIAS3 PIAS2

2.63e-041177227009683
Pubmed

HSP70-Hrd1 axis precludes the oncorepressor potential of N-terminal misfolded Blimp-1s in lymphoma cells.

PIAS3 PIAS2

2.63e-041177228842558
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

FANCD2 NAMPT PEBP1 TBK1 UBR4 SREK1 GALNT5 CMYA5 BSN DDX27 ADGRA3

2.93e-041425771130948266
Pubmed

Hypoxia-induced Slug SUMOylation enhances lung cancer metastasis.

PIAS3 PIAS2

3.15e-041277230612578
Pubmed

Tmeff2 is expressed in differentiating oligodendrocytes but dispensable for their differentiation in vivo.

OLIG1 MYRF

3.15e-041277228336932
Pubmed

Deubiquitinase MYSM1 Regulates Innate Immunity through Inactivation of TRAF3 and TRAF6 Complexes.

TBK1 MAP3K7

3.15e-041277226474655
Pubmed

Foxp1 regulation of neonatal vocalizations via cortical development.

PIAS3 PIAS2

3.71e-041377229138280
Pubmed

K48- and K63-linked ubiquitin chain interactome reveals branch- and length-specific ubiquitin interactors.

TBK1 KHNYN UBR4 HERC2 HERC1 MAP3K7 KANK2

3.87e-0460477738803224
Pubmed

Cytosolic phospholipase A2alpha is crucial [correction of A2alpha deficiency is crucial] for 'on-time' embryo implantation that directs subsequent development.

PLA2G4A PTGS2

4.33e-041477212050136
Pubmed

The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer.

UBR4 HERC2

4.33e-041477227626314
Pubmed

BMP receptor 1A regulates development of hypothalamic circuits critical for feeding behavior.

BMPR1A OLIG1

4.99e-041577223197713
Pubmed

BMP signaling regulates sympathetic nervous system development through Smad4-dependent and -independent pathways.

BMPR1A MAP3K7

4.99e-041577219793887
Pubmed

Talin 1 and 2 are required for myoblast fusion, sarcomere assembly and the maintenance of myotendinous junctions.

BMPR1A MAP3K7

4.99e-041577219793892
Pubmed

A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway.

MOXD1 PTBP2 TBK1 KHNYN MAP3K7

5.66e-0430277530561431
Pubmed

Elevated in vivo levels of a single transcription factor directly convert satellite glia into oligodendrocyte-like cells.

OLIG1 MYRF

5.69e-041677225680202
Pubmed

Dual-mode modulation of Smad signaling by Smad-interacting protein Sip1 is required for myelination in the central nervous system.

OLIG1 MYRF

5.69e-041677222365546
Pubmed

Modifier genes in mice and humans.

PLA2G4A PTGS2

5.69e-041677211256068
Pubmed

SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.

FANCD2 SLAIN2 NAMPT UBR4 HERC2 MAP3K7 GGCX

6.37e-0465777736180527
Pubmed

MIND bomb 2 prevents RIPK1 kinase activity-dependent and -independent apoptosis through ubiquitylation of cFLIPL.

TBK1 MAP3K7

6.44e-041777233469115
Pubmed

Ikaros SUMOylation: switching out of repression.

PIAS3 PIAS2

6.44e-041777215767674
Pubmed

cPGES/p23 is required for glucocorticoid receptor function and embryonic growth but not prostaglandin E2 synthesis.

PLA2G4A PTGS2

7.23e-041877217438133
Pubmed

Chromatin remodeler Ep400 ensures oligodendrocyte survival and is required for myelination in the vertebrate central nervous system.

OLIG1 MYRF

8.07e-041977231081019
Pubmed

TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging.

TBK1 MAP3K7

8.07e-041977230146158
Pubmed

Transcriptomic analysis and novel insights into lens fibre cell differentiation regulated by Gata3.

DCDC2 ATP10D

8.07e-041977231847788
GeneFamilyZinc fingers MIZ-type

PIAS3 PIAS2

1.69e-04752285
GeneFamilyPhospholipases|C2 domain containing phospholipases

PLA2G4A PLCH1

1.34e-0319522832
GeneFamilyAtaxins|Trinucleotide repeat containing

TNRC18 CNPY3

2.33e-0325522775
ToppCellNS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

MOK NUTM1 DCDC2 PHF7 KANK2 CSPP1

3.17e-07157776410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCellprimary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Synpr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

NKD1 PLEKHG3 PLA2G4A OLIG1 MYRF

3.62e-061347753dd4b5eddc94c1d49ab23b287ee234db3a55331b
ToppCelldroplet-Fat-BAT+GAT+MAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DCDC2 PPP1R1B GALNT5 PLCH1 VWCE

1.44e-0517877558857bb8c13e0e1c6d9f5c1258f00fff62063d68
ToppCelldroplet-Fat-BAT+GAT+MAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DCDC2 PPP1R1B GALNT5 PLCH1 VWCE

1.44e-051787758b7df6ab8709d9ab9dff97677cc4561aec2745bc
ToppCelldroplet-Fat-BAT+GAT+MAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DCDC2 PPP1R1B GALNT5 PLCH1 VWCE

1.44e-05178775b0baf5667e3301898b3e45e974b8a8530af6a338
ToppCelldroplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DCDC2 MOXD1 PPP1R1B ARHGEF16 MYRF

1.69e-051847756388c47b7f1d8203e3069eba0e74107256dcae51
ToppCelldroplet-Heart-4Chambers-18m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DCDC2 MOXD1 PPP1R1B ARHGEF16 MYRF

1.69e-05184775d83ae1dc64aa1b27d3b524c137567418cc0ff8c6
ToppCelldroplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MOXD1 PPP1R1B ADAM11 ARHGEF16 PCDH9

1.82e-051877756f7f293c9cf35261e0e3614e46ec1fb00a701b63
ToppCell15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class

MOK LARP6 FRMPD2 ARMC2 C6orf132

2.07e-051927759cbe961a800c981cdc742a47ed18e9c8eb6430bd
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

DCDC2 NKD1 PTBP2 SREK1 MBD5

2.12e-05193775e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MOXD1 NKD1 PLA2G4A PTGS2 ATP10D

2.23e-0519577544d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9
ToppCellSigmoid-(4)_Monocyte|Sigmoid / shred on region, Cell_type, and subtype

RNF144B NAMPT OLIG1 DYSF PTGS2

2.52e-052007757f3920a0434d5199c6c8f0b3064a305bb0d87b60
ToppCellSigmoid-Monocyte-Monocyte|Sigmoid / Region, Cell class and subclass

RNF144B NAMPT OLIG1 DYSF PTGS2

2.52e-05200775010ca36970cb8894bdbca08779c0ecf56be22fc9
ToppCellSigmoid-Monocyte|Sigmoid / Region, Cell class and subclass

RNF144B NAMPT OLIG1 DYSF PTGS2

2.52e-05200775c41bd6ec0f2262fce5cadb37a400d487e6662f49
ToppCellSigmoid-(4)_Monocyte-(40)_Monocyte|Sigmoid / shred on region, Cell_type, and subtype

RNF144B NAMPT OLIG1 DYSF PTGS2

2.52e-05200775576c0a1098e6a934448705de3673ef798fcf1b26
ToppCellIonocyte-iono-4|World / Class top

MOXD1 L3MBTL1 MYRF PCDH9

7.42e-0512977485ee6e16959cb58a58f5b09edf1f78d9ce6a9441
ToppCellfrontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Synpr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

PLEKHG3 PLA2G4A OLIG1 MYRF

9.37e-05137774b03f19b233c1c809f2cd2b4a7642eeaf254a6289
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FANCD2 JCAD PPP1R1B CMYA5

1.47e-0415477412cbc38bc1f7231c67e1d2d5e86e95bc12e24682
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L6_CT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FANCD2 JCAD PPP1R1B CMYA5

1.55e-04156774fe383ce3a0c37f7343d7026cb51260a04d4c2829
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PHF7 ZNF439 PCDH9 ATP10D

1.55e-041567747ece590fd8f29382e349dd0e5e016d2926aeb518
ToppCellAT1-AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

FAM171A2 GALNT5 PTGS2 ZNF541

1.62e-041587743bc51cfd37b289cc3e866b54ce55a298e5eff690
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FANCD2 JCAD PPP1R1B CMYA5

1.79e-0416277458da6bc04cdac0002b0e6a751c96ff95e1a7f70f
ToppCellBasal_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id

LARP6 PLEKHG3 GALNT5 C6orf132

1.96e-04166774aea2ae12e4746149ebc6da063ef694381c098f80
ToppCell10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue

LARP6 PCDH9 PTGS2 PDZD2

2.05e-04168774d02eba7ece17edcdd47fd6b784c93910ce61090f
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

RNF144B MOXD1 PLCH1 ADGRA3

2.05e-041687742572a3dd4f3f619bd26a3cd6e60de43821d8bb64
ToppCellmild_COVID-19_(asymptomatic)-RBC|World / disease group, cell group and cell class (v2)

FANCD2 PHF7 ZNF439 PCDH9

2.10e-041697742bda6ab3f32e05cb7daf91eb7c39b4fcc9ae91bb
ToppCellTCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9

DCDC2 PPP1R1B PLCH1 MYRF

2.15e-04170774d682178d11d67eb5a02d0c6b3967645e37bcc62a
ToppCell10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue

LARP6 PCDH9 PTGS2 PDZD2

2.15e-0417077497df5ffb328196c46568975d2d97722bcc753bf5
ToppCellmild_COVID-19_(asymptomatic)-RBC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)

FANCD2 PHF7 ZNF439 PCDH9

2.20e-0417177478491478ba65bad45238fe114f5251b2adea323d
ToppCellTCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9

DCDC2 PPP1R1B PLCH1 MYRF

2.20e-041717741af575809b3334bfaa019ff26c56e6cb03c82ee8
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

MOXD1 PLA2G4A DYSF PTGS2

2.35e-041747740df738309b7b6e77675ea74e7a87e66601b0073d
ToppCellAdult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor

STXBP5L FMN2 PCDH9 VWDE

2.40e-041757744db1a3c284488b3f6de7568363f176d74e2a4587
ToppCellAdult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor

STXBP5L FMN2 PCDH9 VWDE

2.40e-041757748d9f44a2633b71fb4d2b4a7d9530f954e07c4a18
ToppCellNS-critical-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DCDC2 FRMPD2 VWCE ARMC2

2.45e-04176774b794275fdd757b8fa2108e3c867f23da2649146d
ToppCellAT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id

BMPR1A OLIG1 MYRF PTGS2

2.45e-04176774458720776b0151cd55acc352d509599cb62f0ca8
ToppCelldroplet-Spleen-SPLEEN-1m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZNF174 ADAM11 OLIG1 KANK2

2.56e-04178774742ee0cb8cb585a5e34bd5b20aebe9bb99756e0c
ToppCelldroplet-Limb_Muscle-MUSCLE-1m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAM11 OLIG1 ARHGEF16 PCDH9

2.56e-04178774ef490b45901b2e6dedb519540fa3ae4e4db3a9ba
ToppCell3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HOXB4 MOXD1 C22orf31 ATP10D

2.56e-0417877409475e522dc1b8cf9ff1c25de5d1e3082b162948
ToppCell3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HOXB4 MOXD1 C22orf31 ATP10D

2.56e-0417877435de8f791b0e78a6caf52ff095f05e204a59e828
ToppCell3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HOXB4 MOXD1 C22orf31 ATP10D

2.56e-04178774000d25f3f13cc76cf39c46c312c6fafc2ea4f368
ToppCellLPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DCDC2 PLA2G4A GALNT5 PLCH1

2.61e-04179774fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

DCDC2 GALNT5 MYRF PDZD2

2.61e-041797744f6ca313b78aa93557937a046c44dcf8bcc9963c
ToppCell390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells)

MOXD1 LARP6 C22orf31 KANK2

2.67e-04180774137fc14859c89e1ecd98bee388bb58c04b835847
ToppCell390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells)

MOXD1 LARP6 C22orf31 KANK2

2.67e-04180774cd6790de050151fedfa2c5ea6ad58b72665414b2
ToppCellAT1-AT2_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id

GALNT5 KANK2 MYRF PTGS2

2.73e-04181774ca23ce4f2c7b684d8ddd0e8619b3b696023d75e3
ToppCellEpithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor

STXBP5L FMN2 BSN VWDE

2.78e-0418277457bf4ffb304324e2e392e196336a530d9f78fe0d
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DCDC2 PLA2G4A GALNT5 PLCH1

2.78e-0418277417ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCelldroplet-Heart-4Chambers-18m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DCDC2 PPP1R1B ARHGEF16 MYRF

2.84e-041837742df1611c8acccb2a6f233d3d68bd9df2381a7278
ToppCellLPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DCDC2 PLA2G4A GALNT5 PLCH1

2.84e-04183774e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DCDC2 PLA2G4A GALNT5 PLCH1

2.90e-04184774d0c212a8fbaad24597a84018442b25c61c17ea58
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DCDC2 PLA2G4A GALNT5 PLCH1

2.96e-04185774fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PPP1R1B PLA2G4A PCDH9 PTGS2

2.96e-0418577474b787e225d83efcb84e79c23499febe1a106622
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DCDC2 PLA2G4A GALNT5 PLCH1

2.96e-04185774929b68b05b7686341329ac756d7df172cb4b810b
ToppCellMild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）

MOXD1 ARHGEF16 KANK2 PDZD2

2.96e-04185774c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

RNF144B NAMPT DYSF PTGS2

3.02e-0418677405c40bac5c0ade8b67b7c2112739466e02dbf22b
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPP1R1B ADAM11 OLIG1 ARHGEF16

3.02e-04186774d8d559daff4aeef334d403fde4e3ee2e4a6086d0
ToppCellfacs-BAT-Fat-24m-Epithelial-Epcam+|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MOXD1 PPP1R1B GALNT5 BRWD3

3.02e-04186774b18d7398279a2d42414318aeb70514fd402f5a0a
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DCDC2 PLA2G4A GALNT5 PLCH1

3.02e-04186774e83718fabb057100835d3357df407f283d23fe16
ToppCellFetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

STXBP5L FMN2 BSN VWDE

3.02e-04186774b45cce768e4bf91da194fd9660cab7520dfb15ac
ToppCelldroplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MOXD1 PPP1R1B ARHGEF16 PCDH9

3.09e-041877748e8b147258982b359447add5027318f5b6d51963
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DCDC2 PLA2G4A GALNT5 PLCH1

3.15e-041887744bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCellFetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

STXBP5L FMN2 BSN VWDE

3.15e-04188774c4c3b21ab723b0e9beff9ec84f8d68485f771528
ToppCellCOPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class

RNF144B NAMPT DYSF PTGS2

3.21e-04189774d29f3a0bd23e6eb46389e6eb7ef21851c7b57545
ToppCelldroplet-Pancreas-Endocrine-21m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

JCAD HOXB4 NKD1 DYSF

3.21e-0418977437ce47abd6f96df04d35a4a6189d007bef5ccc94
ToppCellNeuronal_cells-Schwann_cells|World / Lineage and Cell class

NKD1 OLIG1 MYRF PCDH9

3.21e-04189774371cdc92549269e45c23c5a5b3cae9c5d35ee217
ToppCellNeuronal_cells|World / Lineage and Cell class

NKD1 OLIG1 MYRF PCDH9

3.21e-041897743948775a0ebd4b32c1623d5487f5581e6e2934d7
ToppCelldroplet-Pancreas-Endocrine-21m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

JCAD HOXB4 NKD1 DYSF

3.21e-04189774b55324cb365a827d071952709bbf0e8ef8c313de
ToppCellCOPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class

RNF144B NAMPT DYSF PTGS2

3.21e-041897746294691231c7d38707323cf31578a107d3b2c622
ToppCelldroplet-Pancreas-Endocrine-21m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

JCAD HOXB4 NKD1 DYSF

3.21e-0418977462e46d59d3b89d4566b595c704d8b02f1ea9060b
ToppCell5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RNF144B NAMPT OLIG1 PTGS2

3.21e-04189774984b5f21e84dd8273d8437ac2a5a9de4e9484b9a
ToppCellCOPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class

MOK FRMPD2 PLCH1 ARMC2

3.21e-041897743e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCellP15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

MOXD1 PLA2G4A PTGS2 PDZD2

3.28e-04190774d072bb285bd34d518b958e7c9ad44739c60b359c
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPP1R1B ADAM11 OLIG1 ARHGEF16

3.28e-04190774ff3dec5b45c6ea9b5319fb51a0198c6773b7be26
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

RNF144B NAMPT PTGS2 NSMAF

3.28e-04190774212f0d9defcc3174e225cc3d90e7814e238794b6
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPP1R1B ADAM11 OLIG1 ARHGEF16

3.28e-041907744971857eac9af17d66d673ed2ab7072639f60a10
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DCDC2 LARP6 OLIG1 MYRF

3.34e-04191774d45b6aa64667d29ac043c3987902e7f7ddbcf940
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MOXD1 ATXN1 PLA2G4A PTGS2

3.34e-041917741caf726bd07fdca389e678fc16304a6ef1790423
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

RNF144B OLIG1 DYSF PTGS2

3.34e-041917749f0d956e9a14b1cd2c20a52639c6b22c349b377e
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MOXD1 ATXN1 PLA2G4A PTGS2

3.34e-041917743d60c46bced2984c27a1fcf2910bc38b31fb0148
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MOXD1 ATXN1 PLA2G4A PTGS2

3.41e-041927744022f208eb5db760abd0aac782a25e8ab63efc64
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MOXD1 NKD1 PLA2G4A ATP10D

3.41e-04192774bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

DCDC2 NKD1 SREK1 MBD5

3.41e-04192774916fbec1c7ab7969bda711886ac88e877e30c280
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DCDC2 LARP6 OLIG1 MYRF

3.41e-0419277449a34b55788d7ca955936fff1c0501ed674a9f3c
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MOXD1 ATXN1 PLA2G4A PTGS2

3.41e-041927749333aba0d04203ccccad78d82bf6359922f810a7
ToppCell5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RNF144B NAMPT OLIG1 PTGS2

3.41e-0419277462eac1b8aed4fb924946b58c0237313f697a0136
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MOXD1 NKD1 PLA2G4A ATP10D

3.41e-041927740ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

RNF144B OLIG1 DYSF PTGS2

3.48e-0419377445205ad1ef12aabf33059a7ff922a3bb86994c2f
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DCDC2 LARP6 OLIG1 MYRF

3.48e-041937744274c95cedad2ae8c6693ad00deda2b1ba5b5682
ToppCellNS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

MOK FRMPD2 ARMC2 CSPP1

3.48e-04193774ea345d34440b25f65358a53dc72831998d1c3620
ToppCelldroplet-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MOXD1 NAMPT NKD1 PTGS2

3.48e-041937742d891c00b8f0aace17d4c300b63e2341dcffa199
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RNF144B DCDC2 PCDH9 C6orf132

3.48e-04193774263d185af6ed80e639f864e4966268e0862c61dc
ToppCellIPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class

MOK FRMPD2 PLCH1 ARMC2

3.48e-04193774ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RNF144B DCDC2 PCDH9 C6orf132

3.48e-0419377480e058c224749b5fe0ba3e944b48317c2371cb63
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RNF144B DCDC2 PCDH9 C6orf132

3.48e-04193774b991fbbb4618401624f0b3045f0e81a606d3a763
ToppCell10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

LARP6 MYRF PCDH9 ITPKB

3.48e-04193774947200ef6c3a2e35ad7e6b4af29d92384bdf73f5
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

RNF144B DCDC2 PLCH1 ADGRA3

3.55e-04194774e577d9e88390b36b5a09b97fe1026089892275a3
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

NAMPT DYSF PTGS2 NSMAF

3.55e-041947744eef50c38e6edb2ef2cdcd14eb50805f6cd65bc8
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MOXD1 NKD1 PLA2G4A ATP10D

3.55e-04194774240d122dcb9dd1ab2867503ad85869853adcacae
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MOXD1 NKD1 PLA2G4A ATP10D

3.55e-04194774ae7df037592f1c20c9d32be15fe6fc3c562ebeb1
ToppCellIPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class

RNF144B NAMPT PTGS2 ATP10D

3.55e-04194774e8a9005963704286bcc50785bda8d7d63ec001b1
DrugNocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A

JCAD ZNF174 MLLT10 DYSF PIAS2 PCDH9 ITPKB

3.39e-061907677145_DN
DiseaseAsthma, Occupational

PLA2G4A HERC2 PTGS2

1.94e-0610763C0264423
DiseaseConventional (Clear Cell) Renal Cell Carcinoma

BMPR1A PEBP1 FMN2 MLLT10 PTGS2

4.11e-05148765C0279702
DiseaseDuodenal Ulcer

PLA2G4A PTGS2

9.75e-056762C0013295
DiseaseCurling Ulcer

PLA2G4A PTGS2

9.75e-056762C0010474
DiseasePapillary Renal Cell Carcinoma

PEBP1 FMN2 MLLT10 PTGS2

3.40e-04128764C1306837
DiseaseRenal Cell Carcinoma

PEBP1 FMN2 MLLT10 PTGS2

3.40e-04128764C0007134
DiseaseSarcomatoid Renal Cell Carcinoma

PEBP1 FMN2 MLLT10 PTGS2

3.40e-04128764C1266043
DiseaseChromophobe Renal Cell Carcinoma

PEBP1 FMN2 MLLT10 PTGS2

3.40e-04128764C1266042
DiseaseCollecting Duct Carcinoma of the Kidney

PEBP1 FMN2 MLLT10 PTGS2

3.40e-04128764C1266044
Diseaseceramide measurement

PPP1R1B MAP3K7 MYRF ADGRA3 ATP10D

3.58e-04235765EFO_0010222
Diseaselinoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement

MYRF PDZD2

4.25e-0412762EFO_0800500
DiseaseAmyotrophic Lateral Sclerosis

TBK1 PLA2G4A PTGS2

4.58e-0458763C0002736
Diseasehematologic cancer (implicated_via_orthology)

PIAS3 PIAS2

5.01e-0413762DOID:2531 (implicated_via_orthology)
DiseaseFEV change measurement, response to corticosteroid

PLCH1 MAP3K7

5.84e-0414762EFO_0005921, GO_0031960
Diseasemitochondrial heteroplasmy measurement

JCAD LMF2 POLG2

7.61e-0469763EFO_0600008
Diseasefourth ventricle volume measurement

CWF19L2 ATP10D

7.67e-0416762EFO_0010303
Diseasereading and spelling ability

FMN2 ARMC2 PCDH9 DDX27

9.04e-04166764EFO_0005301
DiseaseFebrile seizure (within the age range of 3 months to 6 years)

HERC1 BSN

9.75e-0418762HP_0002373
Diseasestatus epilepticus (implicated_via_orthology)

PPP1R1B PTGS2

1.33e-0321762DOID:1824 (implicated_via_orthology)
DiseaseMalignant neoplasm of breast

LMF2 UBR4 PLA2G4A PHF7 GALNT5 HERC2 DYSF PTGS2 ZNF541

1.74e-031074769C0006142
Diseasechildhood trauma measurement

PLCH1 PCDH9

1.74e-0324762EFO_0007979
Diseasesubcutaneous adipose tissue measurement

ATXN1 MLLT10 ITPKB

1.80e-0393763EFO_0004766
DiseaseColitis

NAMPT PTGS2

1.89e-0325762C0009319
Diseasewellbeing measurement

SLAIN2 DCDC2 PEBP1 PIMREG HERC1 PCDH9 DDX27

2.04e-03692767EFO_0007869
Diseaseurate measurement

MOK CYP1A2 FMN2 PLA2G4A PHF7 MBD5 DYSF REXO1

2.12e-03895768EFO_0004531
Diseasecorpus callosum central volume measurement

MLLT10 PDZD2

2.37e-0328762EFO_0010296
DiseaseAmyotrophic Lateral Sclerosis With Dementia

PLA2G4A PTGS2

2.54e-0329762C0393554

Protein segments in the cluster

PeptideGeneStartEntry
VTPGSNSRRKKGHFR

ZNF280A

66

P59817
LPKSRLGNNEGHSRS

ADGRA3

1206

Q8IWK6
KNGGDQGKRHARASS

ARMC2

221

Q8NEN0
QGKLRGNPHSFAALS

ADAM11

136

O75078
ASKAKTPARHQSFGA

ARHGEF16

96

Q5VV41
GNSHDPGKAKSFRNR

BRWD3

1531

Q6RI45
SSKSKQPAGHRRPAG

C22orf31

126

O95567
NDKSGLHLGKPGHRS

ATXN1

411

P54253
GLPHQRRGGNFKSKS

DDX27

776

Q96GQ7
CGRKSSQTPKLSGRH

ATP10D

36

Q9P241
RGTQDGSKHFVRSPK

NKD1

336

Q969G9
GSKHFVRSPKAQGKS

NKD1

341

Q969G9
ALFKHSKKGPRASGN

CYP1A2

286

P05177
DKGPCRNKLGHSRAS

RNF144B

236

Q7Z419
GRSGKQLKRCHSSQP

HERC2

2761

O95714
PAALAHRKTSAGKGH

JCAD

51

Q9P266
SERSRGGHSKANKPI

HERC1

3246

Q15751
SKKGSRQAHSGPAAL

BSN

3721

Q9UPA5
LGFGRQNFHPLKRKS

MPPE1

6

Q53F39
NLSGFSPRKKPRHHG

L3MBTL1

671

Q9Y468
GFKTKGPLHTRQCNS

PCDH9

1001

Q9HC56
PAANAVKAGGTDHRK

PDZD2

1901

O15018
PILSNRSGDHRGKFK

PEBP1

136

P30086
RSDGRGDKKHSNQKP

CWF19L2

421

Q2TBE0
SNLKHQRFASKAGIP

CSPP1

286

Q1MSJ5
SKPKRGHRKTASFGN

MAP3K7

406

O43318
FKTDHKRGPAFTNGL

PTGS2

196

P35354
AGRRHAATNKLSPSG

LARP6

351

Q9BRS8
PGNVSKLHGRDGRKN

POLG2

316

Q9UHN1
TEKRALGSHRKAGFP

MOK

291

Q9UQ07
RSKLGGFSDDLHKTP

ODF3

166

Q96PU9
RKRGAQKGSGSPTHS

PIMREG

121

Q9BSJ6
SAAHCQGAPGRKLSK

OLIG1

136

Q8TAK6
QGSQRASHLLPAGAK

NUTM1

1046

Q86Y26
HRKLQLSGPSDGNKR

FAM171A2

351

A8MVW0
HKLPNTKIRSGGAAG

HOXB4

221

P17483
ARGAAEAKHKAPGSA

C6orf132

1126

Q5T0Z8
CSNKPSIGKNHRRSG

FAM126A

371

Q9BYI3
RHQLSFLPLKGAGSS

FRMPD2

921

Q68DX3
GARGAHGKKLNFSES

GALNT5

306

Q7Z7M9
SLHKERTGSNRFAKG

CNPY3

111

Q9BT09
HKSKHGSPSLRRKGN

CMYA5

136

Q8N3K9
GTQGKPAIAHRDLKS

BMPR1A

351

P36894
SRGARLPKNLDHGKN

MBD5

1161

Q9P267
NGANRHFTKAKSGGI

NSMAF

91

Q92636
KSQKFLGHPTAGRGR

KANK2

231

Q63ZY3
SKAQHPSRGFAEHGK

KHNYN

601

O15037
SVAAPAKKHRADGGL

FMN2

461

Q9NZ56
AGQTKRTRIHKGNSP

DYSF

246

O75923
GSRKSKGSGNDRHSK

DCDC2

246

Q9UHG0
TPSHRGQLNKEFTGK

FANCD2

896

Q9BXW9
VLLGFAGRNKSGRKH

PIAS2

21

O75928
KLLGPKNSEGLHSAR

PLA2G4A

171

P47712
FPGQKRRISHLSKQG

REXO1

656

Q8N1G1
LRQPVKAFSNHGSGS

SLAIN2

471

Q9P270
GLTKDFGNSPLHRFK

PTBP2

426

Q9UKA9
LAAEPGHGSRKKTAT

LMF2

291

Q9BU23
SKLPQRGQSNRGFHG

PHF7

66

Q9BWX1
AKNGAGSLRSRHLPN

PLEKHG3

46

A1L390
HAGSFKAAANGRILK

ITPKB

676

P27987
KKGRLSLHRTPAGNF

NAMPT

426

P43490
SGKSNERKGGRSRSH

SREK1

181

Q8WXA9
PHGKSQREGRKSESC

STXBP5L

291

Q9Y2K9
KGKKSSAHSSGQRGR

MLLT10

316

P55197
SAQKSGHPFGILKAD

CLEC20A

341

Q6ZU45
VLLGFAGRNKSGRKH

PIAS3

21

Q9Y6X2
EVGFKARGQPKSAHS

TNRC18

1706

O15417
QGRKRHVKPTSGNAF

VWDE

1281

Q8N2E2
GKGFGDSSARIKHQR

ZNF48

146

Q96MX3
GKGFGDSSARIKHQR

ZNF48

226

Q96MX3
KSGQKPGLRHQLGAA

GGCX

351

P38435
KGGKRSLSNRLQHLG

ZNF174

301

Q15697
GPKYHDSNRGTKSLR

MOXD1

156

Q6UVY6
SPHGNVAFSKAGRSL

VWCE

756

Q96DN2
QGLKGLFNKNPRHSS

PLCH1

886

Q4KWH8
RASGEGHHLKSKRPN

PPP1R1B

56

Q9UD71
DGNGKAPSKSELRHL

UBR4

4081

Q5T4S7
GQGATANVFRGRHKK

TBK1

16

Q9UHD2
TSGSARKGKRQHSSP

ZNF541

121

Q9H0D2
GKAFRSAPNLQLHGR

ZNF439

416

Q8NDP4
KAKNSPSLGFHGRAR

MYRF

971

Q9Y2G1